Hongying Zhen

发表

Noninvasive Evaluation of Multidrug Resistance via Imaging of ABCG2/BCRP Multidrug Transporter in Lung Cancer Xenograft Models.

Qi-hua He, Ji-gang Yang, Zhao Chen, 2022, Molecular pharmaceutics.

Inhibition of mouse embryonic carcinoma cell growth by lidamycin through down-regulation of embryonic stem cell-like genes Oct4, Sox2 and Myc

Qi-hua He, Li Shen, Xiaoyan Zhang, 2011, Investigational New Drugs.

Long-term Cultured Human Neural Stem Cells Undergo Spontaneous Transformation to Tumor-Initiating Cells

A. Chang, Qi-hua He, Li Shen, 2011, International journal of biological sciences.

Lidamycin induces neural differentiation of mouse embryonic carcinoma cells through down-regulation of transcription factor Oct4.

Y. Li, Qi-hua He, Juan Zhou, 2012, Biochemical and biophysical research communications.

LyGDI is a Promising Biomarker for Ovarian Cancer

Lijun Ma, Shao-min Yang, Hounan Wu, 2009, International Journal of Gynecologic Cancer.

Quantitative proteomic study of mitoxantrone-resistant NCI-H460 cell-xenograft tumors.

S. Cui, Hongying Zhen, Jiao Liu, 2018, International journal of clinical and experimental pathology.

RNF8-mediated regulation of Akt promotes lung cancer cell survival and resistance to DNA damage.

Fen-Lei F Chang, K. Yan, Jingyu Peng, 2021, Cell reports.

Lidamycin regulates p53 expression by repressing Oct4 transcription.

Juan Zhou, Cheng-shi Quan, Tong Wu, 2014, Biochemical and biophysical research communications.

Identification of novel proteins in chemoresistant lung cancer cells by quantitative proteomics.

Hongying Zhen, Jiao Liu, Li Su, 2018, International journal of clinical and experimental pathology.

Lidamycin induces neural differentiation of mouse embryonic carcinoma cells through down-regulation of transcription factor Oct4.

Y. Li, Qi-hua He, Juan Zhou, 2012, Biochemical and Biophysical Research Communications - BBRC.